Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

KWR vs CBT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
KWR
Quaker Chemical Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$2.46B
5Y Perf.-17.0%
CBT
Cabot Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$4.30B
5Y Perf.+130.7%

KWR vs CBT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
KWR logoKWR
CBT logoCBT
IndustryChemicals - SpecialtyChemicals - Specialty
Market Cap$2.46B$4.30B
Revenue (TTM)$1.93B$3.58B
Net Income (TTM)$4M$285M
Gross Margin34.4%24.8%
Operating Margin3.7%15.7%
Forward P/E19.2x13.2x
Total Debt$929M$1.22B
Cash & Equiv.$180M$258M

KWR vs CBTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

KWR
CBT
StockMay 20May 26Return
Quaker Chemical Cor… (KWR)10083.0-17.0%
Cabot Corporation (CBT)100230.7+130.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: KWR vs CBT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CBT leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Quaker Chemical Corporation is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
KWR
Quaker Chemical Corporation
The Growth Play

KWR is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 2.7%, EPS growth -102.2%, 3Y rev CAGR -1.0%
  • Lower volatility, beta 1.35, Low D/E 67.5%, current ratio 2.42x
  • 2.7% revenue growth vs CBT's -7.0%
Best for: growth exposure and sleep-well-at-night
CBT
Cabot Corporation
The Income Pick

CBT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 4 yrs, beta 0.78, yield 2.1%
  • 115.6% 10Y total return vs KWR's 81.8%
  • Beta 0.78, yield 2.1%, current ratio 1.61x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthKWR logoKWR2.7% revenue growth vs CBT's -7.0%
ValueCBT logoCBTLower P/E (13.2x vs 19.2x)
Quality / MarginsCBT logoCBT8.0% margin vs KWR's 0.2%
Stability / SafetyCBT logoCBTBeta 0.78 vs KWR's 1.35
DividendsKWR logoKWR1.4% yield, 6-year raise streak, vs CBT's 2.1%
Momentum (1Y)KWR logoKWR+44.4% vs CBT's +16.2%
Efficiency (ROA)CBT logoCBT7.4% ROA vs KWR's 0.2%, ROIC 17.4% vs 6.6%

KWR vs CBT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

KWRQuaker Chemical Corporation
FY 2025
Metalworking and Other
67.7%$1.3B
Metals
32.3%$611M
CBTCabot Corporation
FY 2025
Reinforcement Materials
65.2%$2.3B
Performance Chemicals
34.8%$1.3B

KWR vs CBT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCBTLAGGINGKWR

Income & Cash Flow (Last 12 Months)

Evenly matched — KWR and CBT each lead in 3 of 6 comparable metrics.

CBT is the larger business by revenue, generating $3.6B annually — 1.9x KWR's $1.9B. CBT is the more profitable business, keeping 8.0% of every revenue dollar as net income compared to KWR's 0.2%. On growth, KWR holds the edge at +8.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricKWR logoKWRQuaker Chemical C…CBT logoCBTCabot Corporation
RevenueTrailing 12 months$1.9B$3.6B
EBITDAEarnings before interest/tax$143M$731M
Net IncomeAfter-tax profit$4M$285M
Free Cash FlowCash after capex$143M$459M
Gross MarginGross profit ÷ Revenue+34.4%+24.8%
Operating MarginEBIT ÷ Revenue+3.7%+15.7%
Net MarginNet income ÷ Revenue+0.2%+8.0%
FCF MarginFCF ÷ Revenue+7.4%+12.8%
Rev. Growth (YoY)Latest quarter vs prior year+8.5%-3.4%
EPS Growth (YoY)Latest quarter vs prior year+54.8%-23.1%
Evenly matched — KWR and CBT each lead in 3 of 6 comparable metrics.

Valuation Metrics

CBT leads this category, winning 4 of 6 comparable metrics.

On an enterprise value basis, CBT's 6.8x EV/EBITDA is more attractive than KWR's 11.9x.

MetricKWR logoKWRQuaker Chemical C…CBT logoCBTCabot Corporation
Market CapShares × price$2.5B$4.3B
Enterprise ValueMkt cap + debt − cash$3.2B$5.3B
Trailing P/EPrice ÷ TTM EPS-1013.29x13.69x
Forward P/EPrice ÷ next-FY EPS est.19.17x13.23x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple11.86x6.79x
Price / SalesMarket cap ÷ Revenue1.30x1.16x
Price / BookPrice ÷ Book value/share1.80x2.62x
Price / FCFMarket cap ÷ FCF30.51x11.01x
CBT leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

CBT leads this category, winning 6 of 9 comparable metrics.

CBT delivers a 16.8% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $0 for KWR. KWR carries lower financial leverage with a 0.67x debt-to-equity ratio, signaling a more conservative balance sheet compared to CBT's 0.71x. On the Piotroski fundamental quality scale (0–9), CBT scores 6/9 vs KWR's 4/9, reflecting solid financial health.

MetricKWR logoKWRQuaker Chemical C…CBT logoCBTCabot Corporation
ROE (TTM)Return on equity+0.3%+16.8%
ROA (TTM)Return on assets+0.2%+7.4%
ROICReturn on invested capital+6.6%+17.4%
ROCEReturn on capital employed+7.6%+21.3%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.67x0.71x
Net DebtTotal debt minus cash$749M$957M
Cash & Equiv.Liquid assets$180M$258M
Total DebtShort + long-term debt$929M$1.2B
Interest CoverageEBIT ÷ Interest expense1.41x14.72x
CBT leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CBT leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in CBT five years ago would be worth $14,375 today (with dividends reinvested), compared to $6,377 for KWR. Over the past 12 months, KWR leads with a +44.4% total return vs CBT's +16.2%. The 3-year compound annual growth rate (CAGR) favors CBT at 7.5% vs KWR's -11.5% — a key indicator of consistent wealth creation.

MetricKWR logoKWRQuaker Chemical C…CBT logoCBTCabot Corporation
YTD ReturnYear-to-date+2.8%+23.6%
1-Year ReturnPast 12 months+44.4%+16.2%
3-Year ReturnCumulative with dividends-30.6%+24.1%
5-Year ReturnCumulative with dividends-36.2%+43.8%
10-Year ReturnCumulative with dividends+81.8%+115.6%
CAGR (3Y)Annualised 3-year return-11.5%+7.5%
CBT leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

CBT leads this category, winning 2 of 2 comparable metrics.

CBT is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than KWR's 1.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 97.4% from its 52-week high vs KWR's 77.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricKWR logoKWRQuaker Chemical C…CBT logoCBTCabot Corporation
Beta (5Y)Sensitivity to S&P 5001.35x0.78x
52-Week HighHighest price in past year$183.00$84.60
52-Week LowLowest price in past year$99.18$58.33
% of 52W HighCurrent price vs 52-week peak+77.5%+97.4%
RSI (14)Momentum oscillator 0–10056.363.9
Avg Volume (50D)Average daily shares traded178K371K
CBT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — KWR and CBT each lead in 1 of 2 comparable metrics.

Wall Street rates KWR as "Buy" and CBT as "Buy". Consensus price targets imply 24.3% upside for KWR (target: $176) vs -5.4% for CBT (target: $78). For income investors, CBT offers the higher dividend yield at 2.15% vs KWR's 1.39%.

MetricKWR logoKWRQuaker Chemical C…CBT logoCBTCabot Corporation
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$176.33$78.00
# AnalystsCovering analysts1415
Dividend YieldAnnual dividend ÷ price+1.4%+2.1%
Dividend StreakConsecutive years of raises64
Dividend / ShareAnnual DPS$1.97$1.77
Buyback YieldShare repurchases ÷ mkt cap+1.7%+3.9%
Evenly matched — KWR and CBT each lead in 1 of 2 comparable metrics.
Key Takeaway

CBT leads in 4 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency. 2 categories are tied.

Best OverallCabot Corporation (CBT)Leads 4 of 6 categories
Loading custom metrics...

KWR vs CBT: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is KWR or CBT a better buy right now?

For growth investors, Quaker Chemical Corporation (KWR) is the stronger pick with 2.

7% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 13. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Quaker Chemical Corporation (KWR) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — KWR or CBT?

On forward P/E, Cabot Corporation is actually cheaper at 13.

2x.

03

Which is the better long-term investment — KWR or CBT?

Over the past 5 years, Cabot Corporation (CBT) delivered a total return of +43.

8%, compared to -36. 2% for Quaker Chemical Corporation (KWR). Over 10 years, the gap is even starker: CBT returned +115. 6% versus KWR's +81. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — KWR or CBT?

By beta (market sensitivity over 5 years), Cabot Corporation (CBT) is the lower-risk stock at 0.

78β versus Quaker Chemical Corporation's 1. 35β — meaning KWR is approximately 72% more volatile than CBT relative to the S&P 500. On balance sheet safety, Quaker Chemical Corporation (KWR) carries a lower debt/equity ratio of 67% versus 71% for Cabot Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — KWR or CBT?

By revenue growth (latest reported year), Quaker Chemical Corporation (KWR) is pulling ahead at 2.

7% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: Cabot Corporation grew EPS -10. 4% year-over-year, compared to -102. 2% for Quaker Chemical Corporation. Over a 3-year CAGR, KWR leads at -1. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — KWR or CBT?

Cabot Corporation (CBT) is the more profitable company, earning 8.

9% net margin versus -0. 1% for Quaker Chemical Corporation — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus 9. 4% for KWR. At the gross margin level — before operating expenses — KWR leads at 36. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is KWR or CBT more undervalued right now?

On forward earnings alone, Cabot Corporation (CBT) trades at 13.

2x forward P/E versus 19. 2x for Quaker Chemical Corporation — 5. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KWR: 24. 3% to $176. 33.

08

Which pays a better dividend — KWR or CBT?

All stocks in this comparison pay dividends.

Cabot Corporation (CBT) offers the highest yield at 2. 1%, versus 1. 4% for Quaker Chemical Corporation (KWR).

09

Is KWR or CBT better for a retirement portfolio?

For long-horizon retirement investors, Cabot Corporation (CBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

78), 2. 1% yield, +115. 6% 10Y return). Both have compounded well over 10 years (CBT: +115. 6%, KWR: +81. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between KWR and CBT?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: KWR is a small-cap quality compounder stock; CBT is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

KWR

Stable Dividend Mega-Cap

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 20%
Run This Screen
Stocks Like

CBT

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform KWR and CBT on the metrics below

Revenue Growth>
%
(KWR: 8.5% · CBT: -3.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.